Allo-RevCAR01-T clinical trials

Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies

This study is testing a new treatment called Allo-RevCAR01-T-CD123 for adults with a type of blood cancer called Acute Myeloid Leukaemia (AML) that has come back or isn't responding to other treatments. It’s a very early-stage trial (Phase 1) to check if the treatment is safe.